CAROLYN HUBBARD: Open Payments
NPI 1699213363 · CONYERS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,638 in 91 payments from 16 companies in 2025. Trend: 2023 $1,184 · 2024 $1,658 · 2025 $1,638
Food & beverage: $1,638
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 30 | $386 |
| ABBVIE INC. | 18 | $334 |
| PFIZER INC. | 8 | $153 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $151 |
| Janssen Biotech, Inc. | 5 | $111 |
| QOL Medical, LLC | 3 | $87 |
| Phathom Pharmaceuticals, Inc. | 5 | $76 |
| Madrigal Pharmaceuticals | 2 | $65 |
| Ardelyx, Inc. | 2 | $48 |
| Lilly USA, LLC | 2 | $44 |
Products named: XIFAXAN, RINVOQ, ENTYVIO, XELJANZ, TREMFYA, Sucraid, VOQUEZNA, LINZESS.
Industry payments across GA — which companies pay providers there.
